Summary
- Current Price
- As of today, VCYT price is $36.03, up +0.73% on
- Current Price All-Time High
- VCYT price is currently -58.12% below its historical high of $86.03 set on
- Market Cap
- VCYT current market cap is $3B, down -10.92% year-over-year
- PE Ratio
- VCYT current PE ratio is 94.92
- Revenue
- VCYT current annual revenue is $445.76M, up +23.46% year-over-year
- Next Earnings
- The next earnings release for VCYT is on
Profile
| Metric | Value |
|---|---|
| Full Name | Veracyte, Inc. |
| Ticker | NASDAQ: VCYT |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | veracyte.com |
| Employees | 824 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $36.03 | |
| Price, 1D Change | +0.73% | |
| $3B | ||
| - | ||
| 94.92 | ||
| 1.20 | ||
| $446M | ||
| Revenue, 1Y Change | +23.46% | |
| $0.31 | ||
| EPS, 1Y Change | +130.15% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $0.31 | ||
| EPS Estimate | $1.66 | |
| EPS Est. Change | +437.63% | |
| $445.76M | ||
| Revenue Estimate | $511.98M | |
| Revenue Est. Change | +14.85% | |
| Current Price | $36.03 | |
| Price Target | - | $48.00 |
| Price Tgt. Change | - | +33.22% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.73 | -$1.02 | -40.30% | |
| $1.01 | $0.31 | -69.55% | |
| $1.66 | N/A | +437.63% | |
| $1.53 | N/A | +395.95% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $354.83M | $361.05M | +1.75% | |
| $443.25M | $445.76M | +0.57% | |
| $511.98M | N/A | +14.85% | |
| $570.30M | N/A | +27.94% |
🔒 Log In To Unlock Full Data
Performance
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $36.03 | |
| $34.02 | ||
| SMA 200 vs Price | -5.58% | |
| $41.23 | ||
| SMA 50 vs Price | +14.43% | |
| 1.20 | ||
| $1.73 | ||
| 37.66 | ||
| 42.14% | ||
| 56.88% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $445.76M | ||
| $0.31 | ||
| $298.15M | ||
| 66.88% | ||
| $19.51M | ||
| 4.38% | ||
| $24.14M | ||
| 5.42% | ||
| $42.97M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 4.73 | ||
| 4.46 | ||
| 9,755.00 | ||
| 7 | ||
| 10.99 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 94.92 | ||
| 5.75 | ||
| 2.26 | ||
| 35.13 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $1.18B | ||
| $239.09M | ||
| $1.33B | ||
| $372.27M | ||
| $158.05M | ||
| $78.63M | ||
| $50.74M | ||
| $7.50M | ||
| $8.63M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $426.25M | ||
| $278.64M | ||
| $147.62M | ||
| $206.04M | ||
| $23.46M | ||
| $2,000.00 | ||
| $1.61M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $75.10M | ||
| -$56.28M | ||
| $4.90M | ||
| $11.29M | ||
| $63.81M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Morgan Stanley | → | |
| Morgan Stanley | → | |
| UBS | → | |
| Needham | → | |
| Guggenheim | → | |
| Canaccord Genuity | → | |
| Canaccord Genuity | ||
| Freedom Capital Markets | ||
| UBS | → |
Analyst sentiment
Institutional ownership
Screeners with VCYT
FAQ
What is the ticker symbol for Veracyte, Inc.?
The ticker symbol for Veracyte, Inc. is NASDAQ:VCYT
Does Veracyte, Inc. pay dividends?
No, Veracyte, Inc. does not pay dividends
What sector is Veracyte, Inc. in?
Veracyte, Inc. is in the Healthcare sector
What industry is Veracyte, Inc. in?
Veracyte, Inc. is in the Diagnostics & Research industry
What country is Veracyte, Inc. based in?
Veracyte, Inc. is headquartered in United States
When did Veracyte, Inc. go public?
Veracyte, Inc. initial public offering (IPO) was on October 30, 2013
Is Veracyte, Inc. in the S&P 500?
No, Veracyte, Inc. is not included in the S&P 500 index
Is Veracyte, Inc. in the NASDAQ 100?
No, Veracyte, Inc. is not included in the NASDAQ 100 index
Is Veracyte, Inc. in the Dow Jones?
No, Veracyte, Inc. is not included in the Dow Jones index
When was Veracyte, Inc. last earnings report?
Veracyte, Inc.'s most recent earnings report was on November 4, 2025
When does Veracyte, Inc. report earnings?
The next expected earnings date for Veracyte, Inc. is February 25, 2026
Data Sources & References
- VCYT Official Website www.veracyte.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1384101/000138410125000130/0001384101-25-000130-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1384101/000138410125000014/0001384101-25-000014-index.htm
- VCYT Profile on Yahoo Finance finance.yahoo.com/quote/VCYT
- VCYT Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/vcyt